Repligen(RGEN) - 2024 Q4 - Annual Results

Exhibit 99.1 Repligen Corporation 41 Seyon Street Building #1, Suite 100 Waltham, Massachusetts 02453 Repligen Reports Fourth Quarter and Full Year 2024 Financial Results WALTHAM, Mass., February 20, 2025 - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its fourth quarter of 2024, covering the three- and twelve- month periods ended December 31, 2024. The company is also providing financial guidance for the full ...